Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Limb-girdle muscular dystrophy.

Katherine D Mathews1, Steven A Moore

  • 1Departments of Pediatrics and Neurology, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA 52242, USA. katherine-mathews@uiowa.edu

Current Neurology and Neuroscience Reports
|January 1, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regenerative Index: a method to assess muscle regeneration in patients with Duchenne muscular dystrophy.

Skeletal muscle·2026
Same author

Early Clinical, Imaging, and Pathological Characteristics of SRPK3/TTN-Digenic Myopathy.

Annals of clinical and translational neurology·2026
Same author

Natural history of limb girdle muscular dystrophy R1 (LGMDR1): a GRASP consortium study.

Neuromuscular disorders : NMD·2026
Same author

Quantitative Measurement of Glycosylated ⍺-Dystroglycan as a Biomarker for Disease Severity in Limb-Girdle Muscular Dystrophy Type 2I/R9.

Neurology. Genetics·2026
Same author

Early enzyme replacement therapy in late-onset Pompe disease diagnosed by newborn screening.

Molecular genetics and metabolism·2026
Same author

Pathologic Variability Associated With Phenotypic Differences in Siblings With ACTA1 Myopathy.

Muscle & nerve·2026
Same journal

Update on Genetic Chorea.

Current neurology and neuroscience reports·2026
Same journal

Gastrointestinal Dysfunction in Critically Ill Patients With Traumatic Brain Injury: Clinical Implications and Putative Mechanisms: a Narrative Review.

Current neurology and neuroscience reports·2026
Same journal

The Potential of Rehabilitation to Amplify Experience-Induced Myelin Plasticity and Remyelination in Multiple Sclerosis: A Narrative Review.

Current neurology and neuroscience reports·2026
Same journal

The Noradrenergic Brain in Parkinson's Disease.

Current neurology and neuroscience reports·2026
Same journal

Mapping the Silent Onset of Parkinson's Disease: Monoamine Imaging in the Era of the Race for Preclinical Intervention.

Current neurology and neuroscience reports·2026
Same journal

Functional and Structural Brain Imaging Correlates of Treatment Response in Functional Movement Disorder.

Current neurology and neuroscience reports·2026
See all related articles

Limb-girdle muscular dystrophies (LGMDs) present a unified clinical picture but have over 15 genetic causes. Understanding these diverse genetic mechanisms, including unique pathways like the ubiquitin-proteasome system, is crucial for diagnosis.

Area of Science:

  • Neurology
  • Genetics
  • Molecular Biology

Background:

  • Limb-girdle muscular dystrophies (LGMDs) are a heterogeneous group of inherited neuromuscular disorders.
  • Despite a common clinical presentation, LGMDs encompass at least 15 distinct genetic subtypes.
  • Some LGMD subtypes share pathogenic mechanisms with other muscular dystrophies, while others present novel molecular pathways.

Purpose of the Study:

  • To review the genetic heterogeneity of limb-girdle muscular dystrophies.
  • To highlight the diverse pathogenetic mechanisms underlying different LGMD forms.
  • To propose a diagnostic framework for LGMD.

Main Methods:

  • Literature review of genetic forms of LGMD.
  • Analysis of shared and unique pathogenetic mechanisms.

Related Experiment Videos

  • Outline of a diagnostic algorithm.

    • Main Results:

    • Identification of at least 15 genetic forms of LGMD.
    • Categorization of LGMDs based on shared pathogenetic mechanisms (e.g., sarcoglycanopathies, dystrophinopathies) and allelic relationships (e.g., LGMD 1B).
    • Recognition of novel pathogenic mechanisms, such as involvement of the ubiquitin-proteasome pathway in LGMD 2H.

    Conclusions:

    • LGMDs represent a complex spectrum of genetic disorders.
    • Understanding the specific genetic basis and pathogenetic mechanism is essential for accurate diagnosis and potential therapeutic strategies.
    • A combined approach utilizing clinical features, genetic testing, and pathway analysis aids in diagnosing LGMD.